Connective tissue disease-related interstitial lung disease and pulmonary hypertension
Authors:
Open Access
- 1 April 2025
- journal article
- review article
- Published by European Respiratory Society (ERS) in Breathe
- Vol. 21 (2) , 240173
Abstract
Pulmonary hypertension (PH) is an important cause of morbidity and mortality in connective tissue diseases (CTDs) and may develop either in isolation or in combination with interstitial lung disease (ILD). Based on the World Health Organization PH classification into five groups, patients with CTDs typically belong either to group 1 pulmonary arterial hypertension or to group 3 PH due to chronic lung disease and hypoxaemia (PH-ILD). Recent epidemiological studies have delineated the phenotypical complexity of CTD patients who present with both PH and ILD. This review explores the prevalence, diagnosis, pathophysiology, survival and management strategies for CTD-ILD-PH.Keywords
This publication has 40 references indexed in Scilit:
- Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT studyAnnals of the Rheumatic Diseases, 2014
- Scleroderma lung diseaseEuropean Respiratory Review, 2013
- Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survivalEuropean Respiratory Journal, 2013
- Pulmonary hypertension associated with rheumatic diseases: baseline characteristics from the Korean registryInternational Journal of Rheumatic Diseases, 2012
- Systemic sclerosis–related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapiesArthritis & Rheumatism, 2011
- Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEALChest, 2010
- Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: Impact of interstitial lung diseaseArthritis & Rheumatism, 2009
- Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment EraAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Interstitial Lung Disease in Systemic SclerosisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvementArthritis & Rheumatism, 2003